Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...
THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...
Tribune Content Agency on MSN

What is a PSA test and how is it used?

In this two-part series, we'll describe the PSA test-- how it's used, and how doctors perform next steps in the event of an abnormal reading. Our first post addresses PSA screening for prostate cancer ...
Rishi Sunak has urged men to get checked for prostate cancer as part of a new screening drive. The former prime minister has ...
The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...
ATLANTA - Each year, millions of American men get a blood test known as a PSA, or prostate-specific antigen, test as part of their yearly checkup. PSA is a protein produced by the prostate gland. If a ...
Has Joe Biden ever had a prostate-specific antigen or PSA test? It’s a simple blood draw that measures a protein potentially indicating prostate cancer and is nearly always included in a middle-aged ...
According to the American Cancer Society, Black men are one and a half times more likely to get prostate cancer than Caucasian men. And if Black men develop prostate cancer, they are twice as likely ...
The Lehigh Valley Auto Show showcases innovation, creativity, and automotive excellence, drawing car enthusiasts from across the region. This year, it will also put men’s health in the spotlight with ...
WASHINGTON (Reuters) -Former U.S. President Joe Biden had not received a test for prostate cancer, known as a PSA, for more than a decade before he was diagnosed with an advanced form of the disease ...
The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no longer rational to reject prostate cancer screening on one hand while ...